Call Options

7 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$15.43 - $19.06 $75,607 - $93,394
4,900 Added 36.03%
18,500 $313,000
Q2 2024

Aug 14, 2024

SELL
$17.02 - $21.0 $519,110 - $640,500
-30,500 Reduced 69.16%
13,600 $248,000
Q1 2024

May 15, 2024

BUY
$20.45 - $26.49 $182,005 - $235,761
8,900 Added 25.28%
44,100 $953,000
Q4 2023

Feb 14, 2024

BUY
$19.02 - $30.13 $235,848 - $373,612
12,400 Added 54.39%
35,200 $782,000
Q3 2023

Nov 14, 2023

SELL
$30.46 - $46.04 $106,610 - $161,140
-3,500 Reduced 13.31%
22,800 $694,000
Q2 2023

Aug 14, 2023

BUY
$31.57 - $37.73 $429,352 - $513,127
13,600 Added 107.09%
26,300 $982,000
Q1 2023

May 15, 2023

BUY
$29.72 - $41.45 $377,444 - $526,415
12,700 New
12,700 $405,000

Others Institutions Holding INMD

About InMode Ltd.


  • Ticker INMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 83,081,104
  • Market Cap $1.54B
  • Description
  • InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedur...
More about INMD
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.